SCHEMBL22662014

SCHEMBL22662014

c1ccc(-c2ccc(-n3c4ccc(-c5ccc6nc7n(-c8ccccc8)c8ccccc8n7c6c5)cc4n4c5ccccc5nc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
ADORA2B P29275 3/20 0.41
ADORA1 P30542 2/20 0.41
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 4/20 0.39
KDM4E B2RXH2 3/20 0.39
GRIA1 P42261 1/20 0.37
CACNG8 Q8WXS5 1/20 0.37
CACNG2 Q9Y698 1/20 0.37
TYMS P04818 1/20 0.36
AVPR1A P37288 1/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22662010 0.99 ESR1 (0.44) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22662004 0.97 ESR1 (0.45) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22662009 0.97 ESR1 (0.42) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22662005 0.96 MAPK1 (0.42) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22662079 0.96 ESR1 (0.46) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22662238 0.95 ESR1 (0.43) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22662018 0.95 ESR1 (0.45) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22662086 0.95 ESR1 (0.47) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL22661988 0.95 ESR1 (0.47) ESR1ESR2ADORA2BADORA1MAPK1
SCHEMBL21348883 0.95 ESR1 (0.43) ESR1ESR2ADORA2BADORA1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840459-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10840459-B2 Organic electroluminescent materials and devices L1CAM, CHRM1, C1S ESR1 12/4885ESR2 90/4885ADORA2B 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.